en

PRODUCT DETAIL

Glypvilo 50 mg

Code 9871C
MA number 18/0408/18-S
Product Form: tbl 28x50 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 36 - ANTITUSSICA
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH02 Vildagliptin
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 14.12.2018
Validity: 14.12.2023
MA renewed: Renewal application submitted
PIL: PIL_Glypvilo 50 mg_03.2022.pdf  
SPC: SPC_Glypvilo 50 mg_03.2022.pdf  
Safety feature Yes
Data update: 24.06.2021
eu-flag.png sk-flag.png